Bluejay Diagnostics, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Bluejay Diagnostics, Inc. (BJDX) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $281.17 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-12-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2021-12-16
- 2021-09-30: Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month $281.17K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month |
|---|---|
| 2021-09-30 | $281.17K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |